Funding · Healthcare & Life Sciences

Orange Health Labs raises ₹277 crore Series C

By Startup Enthusiast · 22 June 2026

What they do

Orange Health Labs is a full-stack diagnostics platform offering at-home sample collection and own labs

It raised ₹277 crore (~$30 million) in Series C funding led by Iron Pillar India

The company has served over 3 million orders and achieved 65% YoY revenue growth to ₹138 crore in FY26

Orange Health Labs has raised ₹277 crore (~$30 million) in a Series C funding round.
The round was led by Iron Pillar India, which invested ₹156 crore (~$16 million).
Other participants include Crescent Enterprises (₹37.7 crore), Bertelsmann (₹21.8 crore), Accel India (₹8 crore), General Catalyst (₹1.8 crore), Good Capital (₹15.5 crore), and Paramark Frontier Fund (₹37 crore).
The post-money valuation is approximately ₹1,950 crore ($205 million).
Prior to this round, the company had raised about $50 million in total funding.
Previous rounds include a $12 million round in 2024 led by Amazon Sambhav Venture Fund and a $25 million Series B in 2022 led by General Catalyst and Bertelsmann India Investments.
Accel India remains the largest external shareholder with a 15.49% stake post-Series C, while Iron Pillar India holds 8.0%.

India's clinical diagnostics market is expected to reach $4,427.5 million by 2030 at a 10% CAGR (Grand View Research).
Orange Health Labs has achieved 65% YoY revenue growth to ₹138 crore in FY26, with an ARR of ₹180 crore.
Its Bengaluru operations are at 20% EBITDA profitability, and all other city operations are operationally profitable.
The company competes with established players like Dr Lal PathLabs, Redcliffe Labs, and Metropolis India.

Orange Health Labs is a full-stack diagnostics platform offering at-home sample collection and its own NABL-accredited and ICMR-certified labs.
Customers book tests via the app or website, and an eMedic arrives within 30 minutes for home collection.
Reports are delivered within 6 hours for 98% of orders.
The company has 750 eMedics, who hold a diploma or degree in medical lab technology and undergo about 100 hours of training.
It has served over 3 million orders to date and has over 50,000 Google reviews averaging 4.9/5.
Its Net Promoter Score has been above 85 since inception.
The platform handles blood, urine, and genetic tests, and has expanded to Delhi, Mumbai, Hyderabad with over 75 walk-in collection centres since 2024.
Revenue split: 70% from direct consumers via app/website, 30% from corporate partnerships, insurers, employers, and platforms like Amazon (exclusive partner for pharmacy and diagnostics).
It has over 150 corporate partners and over 2,000 clinics onboarded.
The company uses in-house software with AI for eMedic assignment, logistics, and report processing, and is ISO 27001 and SOC 2 certified.

The company plans to expand to new cities, strengthen its omnichannel presence, and widen test categories.

Iron Pillar India (lead) — Growth-stage venture capital firm investing in Indian tech companies.
Crescent Enterprises (participated) — UAE-based diversified business group with a venture capital arm.
Bertelsmann (participated) — German media, services, and education conglomerate with an investment arm.
Accel India (participated) — Venture capital firm; largest external shareholder with 15.49% stake post-Series C.
General Catalyst (participated) — US-based venture capital firm.
Good Capital (participated) — Early-stage venture capital firm focused on Indian startups.
Paramark Frontier Fund (participated) — Venture capital fund investing in high-growth startups.

Product: At-home diagnostics and healthcare platform with rapid sample collection and lab testing
Customers: Individuals and enterprises seeking accessible, rapid preventive healthcare diagnostics
How it makes money: Subscription plans and direct diagnostic testing services through home collection model
What sets it apart: 30-minute home sample collection with AI-driven recommendations for preventive care